#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant neoplasm of choroid Non-Hodgkin's lymphoma unspecified histology indolent Progressive multifocal leukoencephalopathy Pseudoxanthoma elasticum Chondrodystrophy Mucopolysaccharidosis I Richter's syndrome Methylmalonic acidaemia Cardiomyopathy Epileptic encephalopathy Muscular dystrophy Lung adenocarcinoma Chronic granulomatous disease Sarcoidosis Cold type haemolytic anaemia More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Treatment Cytokine release syndrome – Basic Information Primary immunodeficiency syndrome – Trials in Disease Basal cell naevus syndrome – Life with Disease Combined immunodeficiency – Life with Disease Hereditary ataxia – Trials in Disease VEXAS syndrome – Trials in Disease Cytokine release syndrome – Treatment Immunodeficiency congenital – Life with Disease Mantle cell lymphoma refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lonvoguran Immunoglobulin A Lisinopril Dihydrate Dapagliflozin Propanediol Eclitasertib Ethanol, Anhydrous Ethambutol Iclepertin Anhydrous Caffeine Darunavir Ontasameran Risankizumab Nimodipine Cat Epithelium Extract Mk-2060 Istradefylline TIL CELLS Vafidemstat Filgrastim Alemtuzumab More therapies…

    Learn about Your Condition

    Pigmentary glaucoma Skin ulcer Myotonic dystrophy Castleman's disease Upper limb fracture Chorea Glioblastoma multiforme Deafness neurosensory Nodal osteoarthritis Malignant melanoma of eyelid Alport's syndrome Eye inflammation Chronic fatigue syndrome Metastatic glioma Oesophageal carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Safety and Effectiveness of Sirolimus for Treating Drug-Resistant Epilepsy in Children with Rare Brain Disorders Linked to mTOR Pathway Activation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cortical dysplasia
    • Epilepsy
    Investigated Drugs:
    • Sirolimus
    Poland

  • Study on the Effects and Safety of Ginkgo Biloba Extract in Patients with Cognitive Impairment After COVID-19

    Not recruiting

    2 1 1
    Germany Poland Spain

  • Study on the Effects of Phenserine and Donepezil in Patients with Early or Mild Alzheimer’s Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • (-)-PHENSERINE TARTRATE
    • Donepezil Hydrochloride
    Norway

  • Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Masitinib
    France Greece Poland Spain

  • Study of Cenobamate for Children with Partial-Onset Seizures

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Partial seizures
    Investigated Drugs:
    • Cenobamate
    Hungary Spain

  • Study on Cladribine for Treating Secondary Progressive Multiple Sclerosis in Patients with Recent Progression and No Recent Relapses

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Cladribine
    Poland
Previous Page
1 … 90 91 92 93 94 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!